Abstract
Transcriptional organization of blaCTX-M-2 present in a multiresistance plasmid of Salmonella enterica serovar Infantis suggests the presence of more than one promoter involved in the expression of the β-lactamase gene. At least two blaCTX-M-2-specific mRNAs (near to 1 kb and 5 kb) were evidenced. Two +1 signals were detected at −22 bp and −59 bp of blaCTX-M-2 defining two putative promoters.
CTX-M enzymes represent a growing family of class A extended-spectrum β-lactamases (ESBLs) that preferentially hydrolyze cefotaxime over ceftazidime, both oxyimino cephalosporins, including more than 30 members organized in six groups (3). In Argentina, the more prevalent ESBL is CTX-M-2 (20, 22, 23), representative of the CTX-M-2 group (3).
Several reports have identified −35 and −10 promoter regions included in an ISEcp1-like element upstream to blaCTX-M-13 and blaCTX-M-14 (6), blaCTX-M-15 (2, 13), blaCTX-M-17 (4), blaCTX-M-19 (18), blaCTX-M-21 (accession number AJ416346), blaCTX-M-25 and blaCTX-M-26 (15), blaCTX-M-32 (5) and other bla genes encoding CTX-M enzymes (8, 26), involved in the expression of these enzymes.
By contrast, an open reading frame (orf513) associated to unusual class 1 integrons was found upstream to blaCTX-M-2 and blaCTX-M-9 (1, 7, 14, 19, 25, 28). Even if these genes have been suggested to be associated also to ISEcp1 (3), this association has not been confirmed up to now. To our knowledge no data have been reported related to the expression of these enzymes.
In this work we studied the transcriptional organization of blaCTX-M-2 from a Salmonella enterica serovar Infantis plasmid. Plasmid pS21 is a conjugative plasmid from a cefotaxime-resistant Salmonella serovar Infantis clinical isolate (S21). pS21 carries InS21, an unusual class 1 integron with the blaCTX-M-2 gene associated to orf513 (7).
Expression of blaCTX-M-2 in the presence of its upstream region.
A fragment of 1.5 kb (including blaCTX-M-2 plus a 500-bp upstream region), obtained by PCR with Bla2 (5′-GATACCTCGCTCCATTTATTGC) and Bla-down (5′-TTGACTGTCGACCCCAAATCC) from pS21, was cloned into the pCR2.1 vector (Invitrogen), to obtain recombinant plasmid pCRC. The insert of pCRC was then removed by digestion with EcoRI and subcloned into the plasmid vector pPR328 (21). Two recombinant plasmids (pPR328C5 and pPR328C6) with the insert in both orientations were confirmed by sequencing. Both recombinants, regardless of the insert orientation, were resistant to cefotaxime, ampicillin, piperacillin, cephalothin, and aztreonam. Susceptibility was restored in the presence of clavulanic acid (data not shown). After isoelectrofocusing of crude extracts, a single band (pI 8.2) of equivalent intensity with either recombinant could be detected using an iodometric system (with ampicillin [500 μg/ml] or ceftriaxone [1,000 μg/ml] as substrates) (24). Results of this experiment suggested that at least one promoter sequence is present in the 500-bp region upstream to blaCTX-M-2.
Sequence analysis of the regions flanking blaCTX-M-2.
Sequence analysis of the 500-bp region upstream of blaCTX-M-2 in InS21 reveals two different regions: (i) a sequence of 266 bp 96% identical to the upstream region of the KluA-1-encoding gene (a chromosomal β-lactamase from Kluyvera ascorbata; EMBL accession number AJ272538), with identical putative ribosome-binding site sequences (AGAGG) and −10 promoter region (TTGAAG) to those described for other enzymes of same group, but lacking a −35 promoter region (9, 10, 12); and (ii) a distal segment which is 100% identical to the 234-bp common region (CR) downstream of orf513 (CR1) described in unusual class 1 integrons (11) including the right-hand boundary of the CRs (17). A putative promoter in this region (similar to the Escherichia coli consensus promoter) has been proposed for dfrA10 of In7 (16) and could function as another promoter for blaCTX-M-2 expression (Fig. 1A). A 28-bp inverted-repeat region at 6 bp downstream to the blaCTX-M-2 stop codon could operate as a factor-independent transcription terminator (Fig. 1B).
FIG. 1.
Surrounding sequences of blaCTX-M-2 gene and primer extension analysis. A) Sequence analysis of the 500-bp upstream blaCTX-M-2 region. The ATG start codon and the ribosome-binding site are indicated in boldface. The sequence with homology to the upstream region of blaKluA-1 is underlined with a solid line; the −35 and −10 sequences of the P1 promoter are boxed with solid lines; the −35 and −10 sequences of the P2 promoter are boxed with dotted lines. The rest of the sequence corresponds to the 3′ end of the CR1 element; the −10 promoter sequence proposed for blaCTX-M-2-type by Saladin et al. is boxed in dotted lines; the −35 and −10 promoter regions proposed for dfrA10 of In7 are underlined with dotted lines. B) blaCTX-M-2 downstream region. In boldface is indicated the TGA blaCTX-M-2 stop codon; the putative transcription terminator is underlined. C) Primer elongation products (previously treated with ribonuclease) were analyzed by electrophoresis on 6% denaturing polyacrylamide gels using an ALF Express sequencer (Pharmacia). Lane 1, primer elongation products obtained from total RNA of S21 using the Bla-up oligonucleotide. Distances (bp) from the start codon of blaCTX-M-2 are indicated with each arrowhead. Lanes T, G, C, and A, sequencing reactions used as marker. The +1 transcriptional starting sites (−22 and −59 bp) of blaCTX-M-2 are indicated in boldface.
Transcriptional characterization of blaCTX-M-2.
Total RNA was extracted using the FastRNA kit BLUE (BIO 101) according to the manufacturer's recommendations. Samples were dissolved in 0.2% diethyl pyrocarbonate-treated water. The probe used was a 902-bp PCR amplicon produced from pS21 DNA with the Bla1 and Bla2 primers (7), labeled by random primer synthesis employing [α-32P]dCTP (27). Hybridization was performed under high-stringency conditions with an incubation temperature of 42°C for 16 h. At least two blaCTX-M-2 transcripts were detected by Northern blot in S21 (Fig. 2). Considering blaCTX-M-2 gene size, the 0.95- to 1.38-kb blaCTX-M-2-specific transcripts may correspond to monocistronic transcripts. However, larger (5-kb) blaCTX-M-2-positive transcripts were also detected, which may correspond to polycistronic mRNAs.
FIG. 2.
Northern blot. A) RNA (5 to 10 μg) was electrophoresed on a formaldehyde-containing 1.2% agarose gel in MOPS (morpholinepropanesulfonic acid) running buffer. The presence of 23S and 16S rRNA bands showed the integrity of mRNA. B) Autoradiograph where the blaCTX-M-2-specific positive transcripts are detected. M, RNA marker, 0.28 to 6.58 kb (Promega).
The organization of blaCTX-M-2-specific mRNA was explored by reverse transcription-PCR (RT-PCR) strategies (Fig. 3). RNA (3 μg) was reverse transcribed in a final volume of 100 μl using 2 μl hexanucleotide (Promega) or 10 μl reverse primer, 10 μM (Bla2 or Bla-up), according to the Reverse Transcription System (Promega). Ten microliters of RT product was used for specific amplification by PCR experiments in a final volume of 100 μl. RNA samples without RT were used as negative controls. Each RT-PCR was performed in triplicate. Every PCR (I, II, III, and IV) done on S21 RNA subjected to random RT (with hexanucleotides) and directed RT (with Bla2 primer) was positive, and the predicted amplicons were obtained in each case. These results and the presence of blaCTX-M-2-positive transcripts of ∼5 kb suggest that at least one promoter located in CR1 (or even upstream of CR1) could mediate blaCTX-M-2 expression.
FIG. 3.
RT-PCR strategies for blaCTX-M-2 transcript analysis. A) Directed RTs with Bla2 or Bla-up primers and random RT with hexanucleotides. B) PCR amplifications follow each RT. Over the dotted lines, the expected amplicon sizes (kb) are shown. AUG, start codon of blaCTX-M-2 (heavy black line); CR1, 3′ end of common region of In6/In7 (heavy grey line). Primers employed in the directed RTs and PCRs are designated with cardinal numbers (1, Bla1; 2, Bla2; 3, Bla-up; 4, Bla-down) (7).
Primer extension was done using the 5′-labeled Bla-up oligonucleotide (Cy5 ALF Express; Amersham Pharmacia Biotech) complementary to a sequence 97 to 117 bp downstream from the initiation site of the blaCTX-M-2 gene. The extension was performed as described for RT employing 30 μg of RNA and 2 μl of labeled primer (50 pmol/μl). Two +1 signal transcriptional starting sites were identified (Fig. 1C). One of them was located at −22 bp from the start codon of blaCTX-M-2 gene, and the deduced −35 (ACTTTT) and −10 (TTGAAG) boxes of the putative blaCTX-M-2 promoter (P1) were separated by 18 bp. A second transcriptional starting site (−59 bp from the start codon) allowed the proposal of a second putative promoter (P2) with CAGGCT and AGGTTT as −35 and −10 boxes, even if, according to the relative signal intensities of cDNA bands obtained, P1 may be stronger than P2. These two putative promoters defined in this upstream region (P1 and P2) could account for monocistronic transcripts. Based on these data, the −10 region of the P1 promoter sequence was identical to those described by other authors (9, 10, 12). However, the -35 region has not been previously described in any other promoter search (to the best of our knowledge).
Promoter prediction on the 500-bp sequence upstream of blaCTX-M-2 was carried out by Neural Network Promoter Prediction program (http://www.fruitfly.org/seq_tools/promoter.html). Three sequences were detected by this program as putative promoters with a score cutoff at 0.90, all located proximal to the start codon of blaCTX-M-2. One of them included the −10 and −35 regions of the proposed P1 promoter, and the other two sequences contained only the −10 region of the P1 and P2 putative promoters.
Although several putative promoters have been proposed for blaCTX-M-2 group genes by sequence analysis, this is the first experimental characterization of two transcriptional starting sites that support the promoter prediction program results. Putative −35 and −10 promoter sequences were proposed by Saladin et al. (26) in two Proteus mirabilis isolates producing CTX-M-2-type β-lactamases. They employed an internal ISEcp1 forward primer (ISEcp1 U1) containing the typical −35 promoter region, for PCR amplification. However, immediately downstream to this primer, a 17-bp sequence identical to the 3′ end of CR1 (where is included orf513) was described. Considering the 3′ end sequence of CR1, a nonspecific hybridization of the ISEcp1 U1 primer could not be disregarded. The 266-bp sequence present immediately upstream to blaCTX-M-2-type genes in those isolates (where no promoter sequences were searched for [26]) is identical to that analyzed here.
Acknowledgments
J.A.D.C. was a recipient of FOMEC and the European Community, ALFA program, project ALR/B7-3011/94.04-5.0111.9 fellowships. This work was supported in part by grants from the University of Buenos Aires (Buenos Aires, Argentina) (TB 039), CONICET (PID 4413), and SEPCYT (PICT 0693) to G.O.G. and grants from the Ministerio de Ciencia y Tecnología, Spain (BMC-2001-2346), and the European Union (LSHM-CT-2003-503335) to J.A.A.G.O.G. is a member of Carrera del Investigador Científico, CONICET, Argentina.
REFERENCES
- 1.Arduino, S. M., P. H. Roy, G. A. Jacoby, B. E. Orman, S. A. Pineiro, and D. Centrón. 2002. blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob. Agents Chemother. 46:2303-2306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Baraniak, A., J. Fiett, W. Hryniewicz, P. Nordmann, and M. Gniadkowski. 2002. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50:393-396. [DOI] [PubMed] [Google Scholar]
- 3.Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cao, V., T. Lambert, and P. Courvalin. 2002. ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum β-lactamase CTX-M-17. Antimicrob. Agents Chemother. 46:1212-1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cartelle, M., M. Tomas, F. Molina, R. Moure, R. Villanueva, and G. Bou. 2004. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob. Agents Chemother. 48:2308-2313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chanawong, A., F. H. M'Zali, J. Heritage, J. H. Xiong, and P. M. Hawkey. 2002. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob. Agents Chemother. 46:630-637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Di Conza, J., J. Ayala, P. Power, M. Mollerach, and G. Gutkind. 2002. Novel class 1 integron (InS21) carrying the blaCTX-M-2 gene in Salmonella enterica Serovar Infantis. Antimicrob. Agents Chemother. 46:2257-2261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Eckert, C., V. Gautier, M. Saladin-Allard, N. Hidri, C. Verdet, Z. Ould-Hocine, G. Barnaud, F. Delisle, A. Rossier, T. Lambert, A. Philippon, and G. Arlet. 2004. Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48:1249-1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gazouli, M., E. Tzelepi, A. Markogiannakis, N. J. Legakis, and L. S. Tzouvelekis. 1998. Two novel plasmid-mediated cefotaxime-hydrolyzing β-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium. FEMS Microbiol. Lett. 165:289-293. [DOI] [PubMed] [Google Scholar]
- 10.Gazouli, M., E. Tzelepi, S. V. Sidorenko, and L. Tzouvelekis. 1998. Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A β-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis. Antimicrob. Agents Chemother. 42:1259-1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hall, R. M., and C. M. Collis. 1998. Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist. Updat. 1:109-119. [DOI] [PubMed] [Google Scholar]
- 12.Ishii, Y., A. Ohno, H. Taguchi, S. Imajo, M. Ishiguro, and H. Matzusawa. 1995. Cloning and sequence of the gene encoding a cefotaxime-hydrolizing class A β-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 39:2269-2275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Karim, A., L. Poirel, S. Nagarajan, and P. Nordmann. 2001. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 24:237-241. [DOI] [PubMed] [Google Scholar]
- 14.Melano, R., A. Corso, A. Petroni, D. Centrón, B. Orman, A. Pereira, N. Moreno, and M. Galas. 2003. Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum β-lactamases in Klebsiella pneumoniae clinical strain isolated in Argentina. J. Antimicrob. Chemother. 52:36-42. [DOI] [PubMed] [Google Scholar]
- 15.Munday, C. J., D. A. Boyd, N. Brenwald, M. Miller, J. M. Andrews, R. Wise, M. R. Mulvey, and P. M. Hawkey. 2004. Molecular and kinetic comparison of the novel extended-spectrum β-lactamases CTX-M-25 and CTX-M-26. Antimicrob. Agents Chemother. 48:4829-4834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Parsons, Y., R. M. Hall, and H. W. Stokes. 1991. A new trimethoprim resistance gene, dhfrX, in the In7 integron of plasmid pDGO100. Antimicrob. Agents Chemother. 35:2436-2439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Partridge, S. R., and R. M. Hall. 2003. In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob. Agents Chemother. 47:342-349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Poirel, L., J. W. Decousser, and P. Nordmann. 2003. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrob. Agents Chemother. 47:2938-2945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Power, P., M. Galleni, J. Di Conza, J. A. Ayala, and G. Gutkind. 2005. Description of In116, the first blaCTX-M-2-containing complex class 1 integron found in Morganella morganii isolates from Buenos Aires, Argentina. J. Antimicrob. Chemother. 55:461-465. [DOI] [PubMed] [Google Scholar]
- 20.Power, P., M. Radice, C. Barberis, C. D. Mier, M. Mollerach, M. Maltagliatti, C. Vay, A. Famiglietti, and G. Gutkind. 1999. Cefotaxime-hydrolysing β-lactamase in Morganella morganii. Eur. J. Clin. Microbiol. Infect. Dis. 18:743-747. [DOI] [PubMed] [Google Scholar]
- 21.Quigley, N. B., and P. R. Reeves. 1987. Chloramphenicol resistance cloning vector based on pUC9. Plasmid 17:54-57. [DOI] [PubMed] [Google Scholar]
- 22.Quinteros, M., M. Radice, N. Gardella, M. M. Rodríguez, N. Costa, D. Korbenfeld, E. Couto, G. Gutkind, and the Microbiology Study Group. 2003. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob. Agents Chemother. 47:2864-2869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Radice, M., C. Gonzalez, P. Power, M. C. Vidal, and G. Gutkind. 2001. Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg. Infect. Dis. 7:442-443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rossi, A., H. Lopardo, M. Woloj, A. M. Picandet, M. Mariño, M. Galas, M. Radice, and G. Gutkind. 1995. Non-typhoid Salmonella spp. resistant to cefotaxime. J. Antimicrob. Chemother. 36:697-702. [DOI] [PubMed] [Google Scholar]
- 25.Sabaté, M., F. Navarro, E. Miró, S. Campoy, B. Mirelis, J. Barbé, and G.Prats. 2002. Novel complex sul1-type integron in Escherichia coli carrying blaCTX-M-9. Antimicrob. Agents Chemother. 46:2656-2661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Saladin, M., V. T. B. Cao, T. Lambert, J. Donay, J. Herrmann, Z. Ould-Hocine, C. Verdet, F. Delisle, A. Philippon, and G. Arlet. 2002. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209:161-168. [DOI] [PubMed] [Google Scholar]
- 27.Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
- 28.Weill, F. X., R. Lailler, K. Praud, A. Kerouanton, L. Fabre, A. Brisabois, P. A. Grimont, and A. Cloeckaert. 2004. Emergence of extended-spectrum-β-lactamase (CTX-M-9)-producing multiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J. Clin. Microbiol. 42:5767-5773. [DOI] [PMC free article] [PubMed] [Google Scholar]



